Detalhe da pesquisa
1.
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.
Muscle Nerve
; 69(6): 719-729, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593477
2.
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
N Engl J Med
; 383(10): 919-930, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877582
3.
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial.
J Neurol Neurosurg Psychiatry
; 2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577511
4.
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
Muscle Nerve
; 65(3): 291-302, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890069
5.
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Muscle Nerve
; 63(1): 31-39, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063909